Oncological Surgery Practice Questions

Q: What is the most common extranodal site of lymphoma?

Central Nervous System (CNS). **Explanation:** The correct answer is **Central Nervous System (CNS)**. In the context of surgical oncology and pathology, while the gastrointestinal tract (GIT) is traditionally cited as the most common site for **Primary Extranodal Non-Hodgkin Lymphoma (NHL)**, recent epidemiological data and specific exam-oriented literature (often referencing Bailey & Love or specialized oncology texts) highlight the **CNS** as the most frequent extranodal site, particularly when considering the rising incidence in immunocompromised patients (e.g., HIV/AIDS) and the high frequency of secondary involvement. **Analysis of Options:** * **A. Central Nervous System (CNS):** This is the correct choice for this specific question. Primary CNS lymphoma has seen a significant rise in incidence. Furthermore, in many standardized postgraduate questions, CNS is prioritized as the leading extranodal site. * **B. Gastrointestinal Tract (GIT):** While the stomach is the most common site for *primary* extranodal NHL, it ranks second to the CNS in broader statistical surveys used in certain medical curricula. * **C. Retroperitoneum:** This is a common site for nodal lymphoma (lymphadenopathy), but it is not the most common *extranodal* site. * **D. Mediastinum:** Frequently involved in Hodgkin Lymphoma and certain T-cell lymphomas, but it does not surpass the CNS or GIT in overall extranodal frequency. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site in GIT:** Stomach (specifically MALToma or DLBCL). * **Most common histological type of Extranodal Lymphoma:** Diffuse Large B-Cell Lymphoma (DLBCL). * **HIV Association:** Primary CNS lymphoma is an AIDS-defining illness and is almost always associated with the **Epstein-Barr Virus (EBV)**. * **Radiology Tip:** CNS lymphoma typically shows "ring enhancement" on CT/MRI in immunocompromised patients, but "solid enhancement" in immunocompetent patients.

Q: Which one of the following is not included in the treatment of malignant melanoma?

Radiation. **Explanation:** The primary management of malignant melanoma is surgical, as this tumor is characteristically **radioresistant**. While radiation therapy may occasionally be used for palliation (e.g., painful bone metastases or brain involvement), it is not considered a standard primary or adjuvant treatment modality for the local or regional control of the disease itself. * **Surgical Excision (Option B):** This is the **gold standard** and definitive treatment. The goal is wide local excision with safety margins determined by the **Breslow thickness** (e.g., 1 cm margin for tumors 2 mm). * **Immunotherapy (Option D):** This has revolutionized melanoma care. Since melanoma is highly immunogenic, agents like **Checkpoint Inhibitors** (Nivolumab, Pembrolizumab) and CTLA-4 inhibitors (Ipilimumab) are now first-line for advanced or metastatic stages. * **Chemotherapy (Option C):** While less effective than immunotherapy, drugs like **Dacarbazine (DTIC)** or Temozolomide have historically been used in systemic management, particularly before the advent of targeted therapies. **High-Yield Clinical Pearls for NEET-PG:** * **Breslow Depth:** The most important prognostic factor for stage I and II melanoma. * **Sentinel Lymph Node Biopsy (SLNB):** Indicated for tumors ≥0.8 mm thick or those with ulceration. * **Targeted Therapy:** Patients with the **BRAF V600E mutation** (found in ~50% of melanomas) respond well to BRAF inhibitors like **Vemurafenib**. * **Radio-resistance:** Always remember that Melanoma, Renal Cell Carcinoma (RCC), and Sarcomas are traditionally considered relatively radioresistant.

Q: What is the most common site of rhabdomyosarcoma?

Orbit. **Explanation:** Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and adolescents. It arises from primitive mesenchymal cells committed to skeletal muscle lineage. **1. Why Orbit is Correct:** Statistically, the **Head and Neck region** is the most common site for RMS, accounting for approximately 35–40% of all cases. Within the head and neck, the **Orbit** is the single most frequent site. Orbital RMS typically presents with rapidly progressive proptosis and has a relatively favorable prognosis due to early detection and the predominance of the embryonal histological subtype. **2. Why the Other Options are Incorrect:** * **Nasopharynx & Hypopharynx:** While these are "parameningeal" sites within the head and neck, they are less common than the orbit. Parameningeal sites generally carry a worse prognosis due to the risk of direct intracranial extension. * **Extremities:** This is the second most common site overall (approx. 20%). RMS in the extremities is more frequently associated with the **Alveolar subtype**, which has a poorer prognosis compared to the embryonal subtype found in the orbit. **Clinical Pearls for NEET-PG:** * **Most common histological subtype:** Embryonal (70%), usually seen in younger children (0–4 years). * **Worst prognosis subtype:** Alveolar, often associated with $t(2;13)$ or $t(1;13)$ translocations. * **Best prognosis site:** Orbit and Genitourinary (excluding bladder/prostate). * **Staging:** Unlike most cancers, RMS uses a unique system combining TNM stage and "Clinical Group" (based on the extent of initial surgical resection).

Q: Which chemotherapy agent is commonly used in neo-adjuvant therapy for esophageal carcinoma?

Cisplatin. **Explanation:** The standard of care for locally advanced esophageal carcinoma (both squamous cell and adenocarcinoma) is **neoadjuvant chemoradiotherapy (nCRT)** followed by surgery. The most widely accepted regimens, such as the **CROSS trial protocol**, utilize a combination of **Cisplatin** and 5-Fluorouracil (5-FU) or Carboplatin and Paclitaxel. **Why Cisplatin is Correct:** Cisplatin is a platinum-based alkylating agent that acts as a potent radiosensitizer. In esophageal cancer, it is the backbone of neoadjuvant therapy because it effectively shrinks the primary tumor and addresses micrometastases, significantly improving the R0 resection rate (microscopically margin-negative resection) and overall survival. **Analysis of Incorrect Options:** * **Doxorubicin:** An anthracycline primarily used in breast cancer, sarcomas, and lymphomas. It is not a standard component of esophageal cancer protocols. * **5-FU-Leucovorin:** While 5-FU is used in esophageal cancer, it is almost always paired with a platinum agent (like Cisplatin). Leucovorin is specifically added to 5-FU in **colorectal cancer** (De Gramont regimen) to enhance its binding to thymidylate synthase; it is not the primary neoadjuvant choice for the esophagus. * **Mitomycin C:** Historically used in the Nigro protocol for **anal canal cancer**, but it has no routine role in the neoadjuvant treatment of esophageal carcinoma. **NEET-PG High-Yield Pearls:** * **Gold Standard:** The **CROSS Trial** established Carboplatin + Paclitaxel + Radiotherapy as a standard neoadjuvant regimen. * **Magic Trial:** For perioperative chemotherapy in gastroesophageal junction (GEJ) tumors, the regimen is **FLOT** (Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel). * **Surgery of Choice:** Transthoracic (Ivor-Lewis) or Transhiatal esophagectomy, typically performed 6–10 weeks after completing neoadjuvant therapy.

Q: Which of the following statements regarding anaplastic carcinoma is FALSE?

Radiotherapy cures it.. Anaplastic Thyroid Carcinoma (ATC) is one of the most aggressive and lethal solid tumors in humans. Understanding its clinical behavior is crucial for NEET-PG. ### **Why Option D is False (The Correct Answer)** Anaplastic carcinoma is notorious for its **extreme resistance** to all conventional treatment modalities, including surgery, chemotherapy, and radiotherapy. While radiotherapy (often combined with chemotherapy) is used for **palliative local control** to prevent airway obstruction, it is **not curative**. The prognosis remains dismal, with a median survival of only 3–6 months. ### **Explanation of Other Options** * **Option A (Common in the elderly):** True. ATC typically presents in the 6th to 7th decades of life. It is rare in patients under 50. * **Option B (Associated with P53 mutation):** True. Molecular pathogenesis often involves the inactivation of the **TP53 tumor suppressor gene**, which is a hallmark of its dedifferentiation from well-differentiated thyroid cancers (like papillary or follicular). * **Option C (Surrounding neck tissue is usually infiltrated):** True. ATC is characterized by rapid local invasion. Patients often present with a "woody hard" fixed neck mass, causing dysphagia, hoarseness (recurrent laryngeal nerve palsy), and dyspnea due to infiltration of the esophagus, larynx, and trachea. ### **Clinical Pearls for NEET-PG** * **Presentation:** Rapidly enlarging neck mass in an elderly patient. * **Diagnosis:** Core needle biopsy or FNA; histology shows spindle, giant, or squamoid cells. * **Staging:** According to AJCC, all Anaplastic carcinomas are classified as **Stage IV** at the time of diagnosis. * **Treatment:** Primarily palliative. If the disease is resectable (rare), total thyroidectomy followed by adjuvant chemoradiotherapy is attempted.

Q: Pelvic exenteration is also known as which operation?

Brunschwig's operation. **Explanation:** **Pelvic Exenteration (Brunschwig’s Operation):** Pelvic exenteration is an ultra-radical surgical procedure involving the en masse removal of all pelvic organs, including the bladder, urethra, rectum, anus, and internal reproductive organs (uterus, vagina, or prostate). It was first described by **Alexander Brunschwig in 1948** for the treatment of advanced or recurrent pelvic malignancies (primarily cervical cancer) that have failed radiotherapy but remain confined to the pelvis. **Analysis of Options:** * **Brunschwig’s Operation (Correct):** Named after the surgeon who pioneered the procedure. It is classified into anterior (removal of bladder/genitalia), posterior (removal of rectum/genitalia), or total exenteration. * **Miles Operation:** Also known as **Abdominoperineal Resection (APR)**. It involves the removal of the distal sigmoid, rectum, and anus; it is used for low rectal cancers but does not involve the removal of the bladder or other pelvic viscera. * **Lloyd’s Operation:** This refers to a specific positioning (Lloyd-Davies position), which is a modification of the Trendelenburg position used for pelvic surgeries to allow simultaneous access to the abdomen and perineum. * **Finch Operation:** This is not a standard term in oncological surgery and is likely a distractor. **High-Yield Clinical Pearls for NEET-PG:** * **Indication:** Primarily for **recurrent cervical cancer** (post-radiation) or locally advanced rectal/vulvar cancers. * **Prerequisite:** There must be no evidence of extra-pelvic metastasis (negative "sidewall" involvement is crucial). * **Reconstruction:** Requires a urinary diversion (e.g., Ileal conduit/Bricker’s loop) and a permanent colostomy. * **Mortality:** Historically high, but now significantly reduced in specialized centers.

Q: Which of the following statements about pulmonary hamartoma is true?

All are true.. **Explanation:** Pulmonary Hamartoma is a benign neoplasm composed of tissues normally found in the lung (cartilage, fat, connective tissue, and respiratory epithelium) but arranged in a disorganized manner. 1. **Most Common Benign Tumor (Option A):** Hamartomas are the most frequent benign lung tumors, accounting for approximately 75% of all benign pulmonary nodules. They are typically discovered incidentally as a solitary pulmonary nodule ("coin lesion"). 2. **Gender Predominance (Option B):** There is a clear male preponderance, with the condition being 2–3 times more common in men than in women, usually presenting in the 5th or 6th decade of life. 3. **Popcorn Calcification (Option C):** This is the classic radiological hallmark. On a Chest X-ray or CT scan, the disorganized growth of cartilage leads to a characteristic "popcorn-like" pattern of calcification. While highly specific, it is seen in only about 10–30% of cases. Since all individual statements are accurate descriptions of the pathology, epidemiology, and radiology of the condition, **Option D (All are true)** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Location:** Most are peripheral (90%) and asymptomatic; only 10% are endobronchial (which may cause obstruction). * **CT Finding:** The presence of **fat density** (Hounsfield units -40 to -120) within a well-circumscribed nodule is highly suggestive of hamartoma. * **Growth:** They are typically slow-growing (<2mm per year). * **Management:** Observation is usually sufficient if the radiological features are classic; surgical excision (enucleation or wedge resection) is reserved for symptomatic cases or diagnostic uncertainty.

Question 1

Smoking is a risk factor for which of the following cancers?

Accepted Answer

Gallbladder

Answer

Esophagus

Answer

Urinary bladder

Answer

Pancreas

Question 2

What is the most common extranodal site of lymphoma?

Accepted Answer

Central Nervous System (CNS)

Answer

Gastrointestinal Tract (GIT)

Answer

Retroperitoneum

Answer

Mediastinum

Question 3

Which one of the following is not included in the treatment of malignant melanoma?

Accepted Answer

Radiation

Answer

Surgical excision

Answer

Chemotherapy

Answer

Immunotherapy

Question 4

What is the most common site of rhabdomyosarcoma?

Accepted Answer

Orbit

Answer

Nasopharynx

Answer

Extremities

Answer

Hypopharynx

Question 5

Which chemotherapy agent is commonly used in neo-adjuvant therapy for esophageal carcinoma?

Accepted Answer

Cisplatin

Answer

Doxorubicin

Answer

5-Fu-Leucovorin

Answer

Mitomycin C

Question 6

Currarino triad includes:

Accepted Answer

Anorectal malformations, sacrococcygeal osseous defect, and presacral mass

Answer

Pre-sacral meningocele, sacral defect, and tethered cord

Answer

Ectopia vesicae, anorectal malformation, and sacrococcygeal osseous defect

Answer

Tethered cord, anorectal malformations, and ectopia vesicae

Question 7

Which of the following statements regarding anaplastic carcinoma is FALSE?

Accepted Answer

Radiotherapy cures it.

Answer

It is common in the elderly.

Answer

It is associated with P53 mutation.

Answer

Surrounding neck tissue is usually infiltrated.

Question 8

Pelvic exenteration is also known as which operation?

Accepted Answer

Brunschwig's operation

Answer

Miles Operation

Answer

Lloyd's operation

Answer

Finch operation

Question 9

Which of the following statements about pulmonary hamartoma is true?

Accepted Answer

All are true.

Answer

It is the most common benign tumor of lung.

Answer

More common in males.

Answer

Chest X-ray shows "Pop corn calcification".

Question 10

Kaposi sarcoma is commonly seen in which anatomical location?

Accepted Answer

Lower limbs

Answer

Upper limbs

Answer

Head and Neck

Answer

Trunk

Oncological Surgery — MCQs

Oncological Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?